| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | T-tubule | 6.58e-05 | 79 | 21 | 3 | GO:0030315 | |
| GeneOntologyCellularComponent | costamere | 2.19e-04 | 22 | 21 | 2 | GO:0043034 | |
| GeneOntologyCellularComponent | supramolecular fiber | 8.28e-04 | 1179 | 21 | 6 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 8.58e-04 | 1187 | 21 | 6 | GO:0099081 | |
| GeneOntologyCellularComponent | sarcolemma | 8.71e-04 | 190 | 21 | 3 | GO:0042383 | |
| GeneOntologyCellularComponent | sarcomere | 1.89e-03 | 249 | 21 | 3 | GO:0030017 | |
| GeneOntologyCellularComponent | myofibril | 2.46e-03 | 273 | 21 | 3 | GO:0030016 | |
| GeneOntologyCellularComponent | photoreceptor inner segment | 2.76e-03 | 78 | 21 | 2 | GO:0001917 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 2.92e-03 | 290 | 21 | 3 | GO:0043292 | |
| GeneOntologyCellularComponent | specific granule membrane | 3.73e-03 | 91 | 21 | 2 | GO:0035579 | |
| GeneOntologyCellularComponent | secretory granule membrane | 4.16e-03 | 329 | 21 | 3 | GO:0030667 | |
| Domain | PDZ | 7.15e-03 | 141 | 17 | 2 | PF00595 | |
| Domain | PDZ | 7.85e-03 | 148 | 17 | 2 | SM00228 | |
| Domain | - | 8.05e-03 | 150 | 17 | 2 | 2.30.42.10 | |
| Domain | PDZ | 8.16e-03 | 151 | 17 | 2 | PS50106 | |
| Domain | PDZ | 8.26e-03 | 152 | 17 | 2 | IPR001478 | |
| Pathway | REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK | 3.66e-04 | 29 | 14 | 2 | MM14980 | |
| Pathway | REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK | 3.66e-04 | 29 | 14 | 2 | M19861 | |
| Pathway | REACTOME_MTOR_SIGNALLING | 7.35e-04 | 41 | 14 | 2 | M27000 | |
| Pathway | REACTOME_MTOR_SIGNALLING | 7.71e-04 | 42 | 14 | 2 | MM14638 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 27032892 | ||
| Pubmed | A β(IV)-spectrin/CaMKII signaling complex is essential for membrane excitability in mice. | 5.20e-06 | 6 | 21 | 2 | 20877009 | |
| Pubmed | Genome-wide association study of bipolar I disorder in the Han Chinese population. | 5.20e-06 | 6 | 21 | 2 | 20386566 | |
| Pubmed | 2.89e-05 | 300 | 21 | 4 | 28561026 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 2.03e-04 | 497 | 21 | 4 | 36774506 | |
| Pubmed | 2.27e-04 | 963 | 21 | 5 | 28671696 | ||
| Interaction | LYN interactions | 5.41e-06 | 720 | 21 | 7 | int:LYN | |
| Interaction | BSND interactions | 3.90e-05 | 64 | 21 | 3 | int:BSND | |
| GeneFamily | PDZ domain containing | 3.02e-03 | 152 | 10 | 2 | 1220 | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.04e-05 | 114 | 21 | 3 | 1c99483a492d08b6bb745006fe24c22841dc57ad | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_activate-7|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.16e-05 | 132 | 21 | 3 | c07842a4b514f1e950c8af303f3b6b4275906e6a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.71e-05 | 161 | 21 | 3 | 0d863d7d369391dd6148e1de6d6f8033dcb8fe0f | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.94e-05 | 172 | 21 | 3 | 76c06a968d3333441eed103abef1e636a1c3e7a1 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.31e-05 | 175 | 21 | 3 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-05 | 176 | 21 | 3 | c6484334187f64cd00cd35e77d8ae436556b4260 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 8.07e-05 | 181 | 21 | 3 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 8.48e-05 | 184 | 21 | 3 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.61e-05 | 185 | 21 | 3 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 8.61e-05 | 185 | 21 | 3 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 9.18e-05 | 189 | 21 | 3 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 9.32e-05 | 190 | 21 | 3 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | Thalamus-Neuronal|Thalamus / BrainAtlas - Mouse McCarroll V32 | 9.76e-05 | 193 | 21 | 3 | 712a4acd1167e43543950bc819ff11984e6f718d | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 9.76e-05 | 193 | 21 | 3 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.01e-04 | 195 | 21 | 3 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.01e-04 | 195 | 21 | 3 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-04 | 198 | 21 | 3 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| Disease | cognitive inhibition measurement | 5.79e-04 | 50 | 21 | 2 | EFO_0007969 | |
| Disease | Nonorganic psychosis | 1.10e-03 | 69 | 21 | 2 | C0349204 | |
| Disease | Retinitis pigmentosa | 1.26e-03 | 74 | 21 | 2 | cv:C0035334 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 2.33e-03 | 101 | 21 | 2 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | Psychotic Disorders | 2.33e-03 | 101 | 21 | 2 | C0033975 | |
| Disease | Retinitis Pigmentosa | 2.47e-03 | 104 | 21 | 2 | C0035334 | |
| Disease | Ciliopathies | 2.76e-03 | 110 | 21 | 2 | C4277690 | |
| Disease | bipolar I disorder | 4.49e-03 | 141 | 21 | 2 | EFO_0009963 | |
| Disease | Alzheimer disease | 4.71e-03 | 485 | 21 | 3 | MONDO_0004975 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SASSPPLHTWLTVLK | 41 | Q01362 | |
| KSLKSSDPWHPPSLS | 176 | Q8TF63 | |
| WKATHPPSSSLPNPL | 461 | Q08289 | |
| VSPRHSPWSSPKLPK | 391 | Q6P5Q4 | |
| LPSKPSWPSEKARLT | 136 | Q8WV28 | |
| KLSSHRTKSSGWPPP | 11 | Q14CM0 | |
| PLKSIWSVSTPSPIK | 1536 | Q12955 | |
| PKSKARPSSPSTSWH | 461 | Q3KQU3 | |
| SSSLTHWKKLPPLPS | 96 | Q6IAA8 | |
| HWKKLPPLPSLTSQP | 101 | Q6IAA8 | |
| PPVAKSLPSSLLLSW | 2061 | O75445 | |
| SLPSSLLLSWNPPKK | 2066 | O75445 | |
| TKHWSSSSASPPPKK | 156 | A6NNA2 | |
| LKKCPHSTPLWLLLS | 736 | O94906 | |
| KSPSVTFPKWLSHPV | 141 | Q9BSH3 | |
| ELALWTPTLPKKPTS | 216 | Q8WYR4 | |
| KIPSLGWSPSKHTKT | 586 | Q8IVF2 | |
| LSLFSLWLSSKPPSK | 116 | Q8IWU4 | |
| PSWKHKLSQAPLLPS | 101 | Q92574 | |
| WILPKPHISSTPLTI | 961 | Q6ZVD8 | |
| KSDPPTLLTPSKWSV | 251 | O94804 | |
| SWSALKAPKSLPTHL | 66 | Q6P2S7 | |
| ILSHSWLQPPKPKAT | 266 | Q96PF2 |